EUVIMEDEUVIMED entdecken
Crossref

Improving Detection of CIN2+ and CIN3+ Lesions: Evaluation of E6/E7 mRNA, P16, and Ki‐67, Individually and in Combination

Yingmei Huang, Feng Liang, Jianyong Huang, Hongmian Jiang, Jing Chen, Baoli Xie iD

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Yingmei Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Department, The First People's Hospital of Nanning, Nanning, Guangxi Zhuang Autonomous Region, China. Hauptthemen laut MEDLINE: Ki-67 Antigen, Uterine Cervical Dysplasia, Cyclin-Dependent Kinase Inhibitor p16, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytology screening has lower cervical precancer sensitivity than HPV DNA testing, which lacks specificity. To overcome this limitation, we assessed the diagnostic performance of E6/E7 mRNA, P16, and Ki‐67, both alone and in combination, in detecting cervical intraepithelial neoplasia grade 2 or higher (CIN2+). A total of 403 cervical samples were collected from the First People's Hospital of Nanning between January 2019 and January 2024, and each biomarker was evaluated for its diagnostic accuracy. E6/E7 mRNA showed moderate performance, with 68.2% sensitivity and 61.8% specificity in detecting CIN2+ lesions. P16 exhibited superior performance, achieving 82.2% sensitivity and 90.1% specificity. Although Ki‐67 showed the highest sensitivity at 95%, it had the lowest specificity at 27.2%. The combination of P16 and Ki‐67 yielded the best diagnostic results, with 90% sensitivity and 79.8% specificity for CIN2+, representing a significant enhancement over individual biomarkers. These findings highlight the superior accuracy of P16, especially when combined with Ki‐67, in detecting both CIN2+ and CIN3+ lesions. This approach improves high‐risk lesion detection by reducing false negatives. Incorporating P16/Ki‐67 biomarkers enhances screening sensitivity/specificity and clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ki-67 AntigenUterine Cervical DysplasiaCyclin-Dependent Kinase Inhibitor p16Uterine Cervical NeoplasmsPapillomavirus InfectionsOncogene Proteins, ViralHumansFemaleRNA, MessengerSensitivity and SpecificityAdultMiddle AgedEarly Detection of CancerBiomarkers, TumorPapillomavirus E7 Proteins

Stichwörter der Autor:innen

E6/E7 mRNAKi‐67P16cervical cancer screeningcervical intraepithelial neoplasia (CIN)

Substanzen

Ki-67 AntigenCyclin-Dependent Kinase Inhibitor p16RNA, MessengerCDKN2A protein, humanOncogene Proteins, ViralBiomarkers, TumorPapillomavirus E7 Proteins

Autor:innen und Institutionen

  • Gynecology Department, The First People's Hospital of Nanning, Nanning, Guangxi Zhuang Autonomous Region, China.
  • Gynecology Department, The Reproductive Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, China.
  • Pathology Department, The First People's Hospital of Nanning, Nanning, Guangxi Zhuang Autonomous Region, China.

ORCID-Profile: Baoli Xie

Zitieren

APA

Huang, Y., Liang, F., Huang, J., Jiang, H., Chen, J., & Xie, B. (2025). Improving Detection of CIN2+ and CIN3+ Lesions: Evaluation of E6/E7 mRNA, P16, and Ki‐67, Individually and in Combination. Journal of Medical Virology. https://doi.org/10.1002/jmv.70405

Vancouver

Huang Y, Liang F, Huang J, Jiang H, Chen J, Xie B. Improving Detection of CIN2+ and CIN3+ Lesions: Evaluation of E6/E7 mRNA, P16, and Ki‐67, Individually and in Combination. Journal of Medical Virology. 2025. doi:10.1002/jmv.70405

BibTeX
@article{Huang2025,
  author = {Huang, Yingmei and Liang, Feng and Huang, Jianyong and Jiang, Hongmian and Chen, Jing and Xie, Baoli},
  title = {Improving Detection of CIN2+ and CIN3+ Lesions: Evaluation of E6/E7 mRNA, P16, and Ki‐67, Individually and in Combination},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70405}
}
Kostenlos starten →